These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 3946462)
1. Lipids and hypertension. Implications of new guidelines for cholesterol management in the treatment of hypertension. Grimm RH; Hunninghake DB Am J Med; 1986 Feb; 80(2A):56-63. PubMed ID: 3946462 [TBL] [Abstract][Full Text] [Related]
3. Effects of prazosin on serum lipids in patients with essential hypertension: a review of the findings presented at the Satellite Symposium on coronary heart disease: hypertension and other risk factors, Milan, 1983. Lowenstein J Am J Cardiol; 1984 Jan; 53(3):21A-23A. PubMed ID: 6141723 [TBL] [Abstract][Full Text] [Related]
4. Management of hypertension. Potential trade-offs on coronary risk. Grimm RH; Flack JM Am J Med; 1989 Aug; 87(2A):62S-65S. PubMed ID: 2669474 [TBL] [Abstract][Full Text] [Related]
6. Antihypertensive therapy and lipids. Paradoxical influences on cardiovascular disease risk. Weinberger MH Am J Med; 1986 Feb; 80(2A):64-70. PubMed ID: 2868658 [TBL] [Abstract][Full Text] [Related]
7. Studies on the effect of prazosin on blood pressure and serum lipids in Japanese hypertensive patients. Saruta T Am J Med; 1984 Feb; 76(2A):117-21. PubMed ID: 6367447 [TBL] [Abstract][Full Text] [Related]
8. Lipids, lipoproteins, and coronary heart disease: implications for antihypertensive therapy. Feher MD; Betteridge DJ Cardiovasc Drugs Ther; 1989 Jun; 3 Suppl 1():333-40. PubMed ID: 2487804 [TBL] [Abstract][Full Text] [Related]
9. Effects of prazosin and propranolol on blood lipids and lipoproteins in hypertensive patients. Velasco M; Hurt E; Silva H; Urbina-Quintana A; Hernández-Pieretti O; Feldstein E; Camejo G Am J Med; 1986 Feb; 80(2A):109-13. PubMed ID: 3080882 [TBL] [Abstract][Full Text] [Related]
10. Effects of oral antihypertensive agents on blood lipid levels. Leren P Clin Ther; 1986; 8(3):309-19. PubMed ID: 2872961 [TBL] [Abstract][Full Text] [Related]
11. [Antihypertensive therapy and modification of metabolic risk factors (glucose and lipid metabolism)]. Klein W Z Kardiol; 1992 Jun; 81(6):295-302. PubMed ID: 1353932 [TBL] [Abstract][Full Text] [Related]
12. [Prazosin in the treatment of hypertension: effect on lipid metabolism]. Hitzenberger G; Neumann K; Dietz S; Egger H; Hariri K; Kittler E; Niedrist W; Nitsch-Fritz R; Ravanelli O; Sapinsky H Wien Med Wochenschr; 1987 Nov; 137(22):525-30. PubMed ID: 3433787 [TBL] [Abstract][Full Text] [Related]
13. Effects of prazosin, atenolol, and thiazide diuretic on plasma lipids in patients with essential hypertension. Neusy AJ; Lowenstein J Am J Med; 1986 Feb; 80(2A):94-9. PubMed ID: 3511694 [TBL] [Abstract][Full Text] [Related]
14. A long-term nutrition intervention experience: lipid responses and dietary adherence patterns in the Multiple Risk Factor Intervention Trial. Dolecek TA; Milas NC; Van Horn LV; Farrand ME; Gorder DD; Duchene AG; Dyer JR; Stone PA; Randall BL J Am Diet Assoc; 1986 Jun; 86(6):752-8. PubMed ID: 3519737 [TBL] [Abstract][Full Text] [Related]
15. Coronary heart disease and the treatment of hypertension: impact of diuretics on serum lipids and glucose. Ames RP J Cardiovasc Pharmacol; 1984; 6 Suppl 3():S466-73. PubMed ID: 6208413 [TBL] [Abstract][Full Text] [Related]
16. Interactions between antihypertensive agents, serum lipids and cigarette smoking in high risk hypertensive patients. Plouin PF J Hum Hypertens; 1989 Dec; 3 Suppl 2():49-53; discussion 53-4. PubMed ID: 2575176 [TBL] [Abstract][Full Text] [Related]
17. Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial. Lasser NL; Grandits G; Caggiula AW; Cutler JA; Grimm RH; Kuller LH; Sherwin RW; Stamler J Am J Med; 1984 Feb; 76(2A):52-66. PubMed ID: 6367451 [TBL] [Abstract][Full Text] [Related]